These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin. Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386 [TBL] [Abstract][Full Text] [Related]
6. An 81 year old man with a blistering rash. Noel S; Dua J; Kaushal G BMJ; 2013 Jan; 346():f522. PubMed ID: 23369776 [No Abstract] [Full Text] [Related]
11. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405 [TBL] [Abstract][Full Text] [Related]
12. The blistering diseases. Scott JE; Ahmed AR Med Clin North Am; 1998 Nov; 82(6):1239-83. PubMed ID: 9889748 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany. Hübner F; Recke A; Zillikens D; Linder R; Schmidt E J Invest Dermatol; 2016 Dec; 136(12):2495-2498. PubMed ID: 27456755 [No Abstract] [Full Text] [Related]
14. Retrospective analysis of autoimmune bullous diseases in Middle Franconia. Sollfrank L; Schönfelder V; Sticherling M Front Immunol; 2023; 14():1256617. PubMed ID: 37881435 [TBL] [Abstract][Full Text] [Related]
15. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence. Gardner KM; Crawford RI J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980 [TBL] [Abstract][Full Text] [Related]
16. The Value of Type IV Collagen Immunohistochemical Staining in the Differential Diagnosis of Autoimmune Subepidermal Bullous Diseases. Yeol Lee H; Ham SP; Choi YW; Park HJ Acta Dermatovenerol Croat; 2018 Jun; 26(2):133-138. PubMed ID: 29989869 [TBL] [Abstract][Full Text] [Related]
17. Bullous diseases: Kids are not just little people. Marathe K; Lu J; Morel KD Clin Dermatol; 2015; 33(6):644-56. PubMed ID: 26686016 [TBL] [Abstract][Full Text] [Related]
18. Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). Ujiie H; Iwata H; Yamagami J; Nakama T; Aoyama Y; Ikeda S; Ishii N; Iwatsuki K; Kurosawa M; Sawamura D; Tanikawa A; Tsuruta D; Nishie W; Fujimoto W; Amagai M; Shimizu H; J Dermatol; 2019 Dec; 46(12):1102-1135. PubMed ID: 31646663 [TBL] [Abstract][Full Text] [Related]
19. U-serrated and n-serrated patterns in bullous pemphigoid, epidermolysis bullosa acquisita, and bullous lupus: A retrospective observational study. Barker CS; Bruner E; Self S; Elston DM J Am Acad Dermatol; 2024 Jun; 90(6):1282-1284. PubMed ID: 38368951 [No Abstract] [Full Text] [Related]
20. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]